Applying the adverse outcome pathway concept for assessing non-monotonic dose responses: biphasic effect of bis(2-ethylhexyl) phthalate (DEHP) on testosterone levels
Maria Chiara Astuto, D. Benford, Laurent Bodin, I. Cattaneo, Þórhallur I. Halldórsson, J. Schlatter, Richard M. Sharpe, José Tarazona, Mamoun Younes
Topics & Concepts
PhthalateDibutyl phthalateAdverse effectTestosterone (patch)Adverse Outcome PathwayRisk assessmentBenzhydryl compoundsMedicinePsychologyPhysiologyToxicologyEndocrinologyPharmacologyInternal medicineChemistryBiologyBisphenol AComputer scienceComputational biologyComputer securityOrganic chemistryEpoxyEffects and risks of endocrine disrupting chemicalsAnimal testing and alternativesToxic Organic Pollutants Impact